FODDAI, SILVIA GRAZIETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.143
EU - Europa 931
AS - Asia 564
SA - Sud America 108
AF - Africa 26
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.776
Nazione #
US - Stati Uniti d'America 1.046
IT - Italia 403
SG - Singapore 234
CN - Cina 186
ES - Italia 86
IE - Irlanda 85
MX - Messico 76
DE - Germania 60
BR - Brasile 41
SE - Svezia 41
FR - Francia 37
IN - India 34
RU - Federazione Russa 30
GB - Regno Unito 29
FI - Finlandia 26
RO - Romania 20
CO - Colombia 18
HK - Hong Kong 18
ID - Indonesia 18
PL - Polonia 18
AR - Argentina 17
AT - Austria 16
NL - Olanda 13
JP - Giappone 12
TR - Turchia 11
VN - Vietnam 11
CA - Canada 10
CH - Svizzera 9
EC - Ecuador 9
PE - Perù 9
CL - Cile 8
EG - Egitto 8
KR - Corea 8
PT - Portogallo 8
TW - Taiwan 8
BE - Belgio 7
HU - Ungheria 7
UA - Ucraina 7
IL - Israele 6
IR - Iran 6
MA - Marocco 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
MT - Malta 4
RS - Serbia 4
SI - Slovenia 4
TN - Tunisia 4
VE - Venezuela 4
AU - Australia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
SA - Arabia Saudita 3
SN - Senegal 3
AM - Armenia 2
HR - Croazia 2
LV - Lettonia 2
NI - Nicaragua 2
PH - Filippine 2
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
JM - Giamaica 1
LT - Lituania 1
MY - Malesia 1
PK - Pakistan 1
UY - Uruguay 1
Totale 2.776
Città #
Santa Clara 194
Chandler 146
Singapore 141
Turin 115
Dublin 85
Sesto San Giovanni 63
Ann Arbor 45
Torino 44
Ashburn 43
Beijing 39
Fairfield 32
Columbus 31
Medford 30
Nyköping 30
New York 26
Madrid 23
Wilmington 23
Rome 21
Giussano 19
Paris 19
Jakarta 18
Mexico City 18
Hangzhou 17
Princeton 17
Helsinki 16
Córdoba 15
Milan 15
Vienna 14
Hong Kong 13
Los Angeles 13
Chicago 11
Chengdu 10
Falls Church 10
Hebei 10
Houston 10
Seattle 10
Bengaluru 9
Bologna 9
Düsseldorf 9
Guiyang 9
Redwood City 9
Shanghai 9
Wuhan 9
Dong Ket 8
Nuremberg 8
São Paulo 8
Brasov 7
Cambridge 7
Cuenca 7
Jacksonville 7
Lima 7
Lisbon 7
Seoul 7
Berlin 6
Frankfurt am Main 6
Guadalajara 6
Hyderabad 6
Mexico 6
San Diego 6
Seville 6
Silver Spring 6
Wroclaw 6
Agliè 5
Bari 5
Boston 5
Brussels 5
Bucharest 5
Budapest 5
Chongqing 5
Lappeenranta 5
Lauterbourg 5
Mumbai 5
Novosibirsk 5
Padova 5
Ravenna 5
Terrassa 5
Toronto 5
Valencia 5
Washington 5
Acton 4
Barcelona 4
Belgrade 4
Bogotá 4
Brescia 4
Bucaramanga 4
Cairo 4
Delhi 4
Ecatepec 4
Freiburg im Breisgau 4
Ljubljana 4
Manchester 4
Medellín 4
San Francisco 4
Sheffield 4
Syracuse 4
Vitória 4
Woodbridge 4
Yuncheng 4
Zapopan 4
Amsterdam 3
Totale 1.744
Nome #
Treatment of antiphospholipid syndrome 328
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 306
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 255
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 144
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 123
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 113
Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS) 105
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology 105
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 92
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 84
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies 81
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome 80
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation 80
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities 76
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study 74
Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing 71
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach 68
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 59
Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/ prothrombin antibodies 53
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study 53
Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients 49
2023 ACR/EULAR classification criteria in existing research cohorts: an international study 44
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head 40
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review 40
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies 39
Serum Biomarkers of Renal Fibrosis: A Systematic Review 34
New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing 33
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository 30
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) (vol 122, pg 1612, 2022) 27
Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation 27
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 26
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review 24
Thrombosis and APS: Lessons Learned from Another Black Swan Tale 23
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab 17
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain 16
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence 14
The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance—A Patient-Driven, Multistep-Approach Study 8
Totale 2.841
Categoria #
all - tutte 11.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 1 5
2020/2021126 2 9 12 7 11 9 2 14 20 10 8 22
2021/2022375 17 35 34 13 43 30 26 17 28 19 47 66
2022/2023703 57 66 40 54 69 128 63 54 51 23 60 38
2023/2024698 61 73 66 35 80 73 37 41 19 55 37 121
2024/2025926 55 58 46 105 275 98 75 81 94 39 0 0
Totale 2.841